Rufe talla

Samsung ya sanar, cewa IHRN (Sanarwar Rhythm na Zuciya mara ka'ida) na sashin aikin ECG na yanzu akan Galaxy Watch samu izini daga US FDA (Abinci da Drug Administration). Masu amfani Galaxy Watch s Wear OSs ba da daɗewa ba za su iya amfani da firikwensin BioActive don neman alamun fibrillation.

Samsung ya ce fasalin IHRN da FDA ta amince zai fara fitowa a agogon Galaxy Watch6, wanda ya kamata ya gabatar a lokacin rani. Galaxy Watch6 a fili zai ƙunshi madaidaicin ƙirar ƙira da ƙirar Classic, wanda yakamata ya sami jujjuyawar jiki lunette.

Giant ɗin na Koriya ya kara da cewa fasalin, wanda zai bincikar bugun zuciya da ba daidai ba a bango ta amfani da firikwensin BioActive lokacin da aka kunna shi a cikin app na Samsung Health Monitor, daga baya za a mika shi zuwa tsoffin agogo. Galaxy Watch tare da wannan firikwensin, wanda shine layuka Galaxy Watch4 zuwa Watch5. An kuma tabbatar da wannan dalla-dalla dalla-dalla ta sabuntawa mai zuwa tare da babban tsari na UI 5 Watch, wanda zai zo ne kawai akan agogo tare da tsarin Wear OS, ba akan tsofaffin samfura masu ƙarfin Tizen ba kamar Galaxy Watch3.

Dangane da sabbin leaks na Samsung kwanan nan, jerin Galaxy Watch6 za ta yi mataki na ƙarshe Yuli. Sabuntawa tare da UI 5 Watch yakamata a sake shi jim kadan bayan haka. Ɗayan UI 5 tsawo Watch, wanda giant na Koriya ya gabatar a karshe mako, zai kawo, a tsakanin sauran abubuwa, keɓaɓɓen yankuna na bugun zuciya da ingantattun fasalulluka na aminci kamar gano faɗuwa da kiran SOS ta atomatik.

Kuna iya siyan agogon smart na Samsung anan

Wanda aka fi karantawa a yau

.